EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease

Tomomi Kogiso iD, Kayo Takayanagi, Tsutomu Ishizuka, Motoyuki Otsuka iD, Kei Inai, Yuri Ogasawara, Kentaro Horiuchi, Makiko Taniai, Katsutoshi Tokushige

PLOS ONE · 02.01.2024 · 19 (1) · e0296375

DOI: 10.1371/journal.pone.0296375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 02.01.2024. Verfasst von Tomomi Kogiso und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology,, Japan Agency for Medical Research and Development, National Center for Global Health and Medicine, Grant/Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic liver disease leads to liver fibrosis, and an accurate diagnosis of the fibrosis stage is crucial for medical management. Connective tissue growth factor (CTGF) is produced by endothelial cells and platelets and plays a central role in inducing fibrosis in various organs. In the present study, we tested the validity of measuring the serum levels of two types of CTGF to estimate the biopsy-confirmed liver fibrosis stage.

Methods

We used two detection antibodies targeting the N- and C-terminal of CTGF to measure the serum levels of two forms of CTGF consisting of its full length and its N-terminal fragment. We analyzed the level of CTGF (via enzyme-linked immunosorbent assay) and the liver fibrosis stage in 38 patients with Fontan-associated liver disease (FALD) (26 cases of which were diagnosed pathologically). Correlations were determined by multivariate analysis and the area under the receiver operating characteristic curve. The 65 patients with nonalcoholic fatty liver disease (NAFLD) were included as a disease control group for examination.

Results

Full-length CTGF was significantly inversely correlated with liver fibrosis in patients with FALD. Although the platelet count was also associated with the liver fibrosis stage, full-length CTGF was more closely correlated with the fibrosis stage. Furthermore, the level of full-length CTGF was inversely associated with high central venous pressure. Conversely, the serum level of CTGF was not correlated with the fibrosis stage in NAFLD.

Conclusion

The serum level of full-length CTGF may be useful for estimating the liver fibrosis stage in patients with FALD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHumansConnective Tissue Growth FactorEndothelial CellsLiverLiver Cirrhosis

Substanzen

Connective Tissue Growth Factor

Autor:innen und Institutionen

  • Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Tokyo, Japan.
  • Division of Transplant Immunology, Central Clinical Laboratories, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
  • Department of Pediatric Cardiology and Adult Congenital Cardiology, Tokyo Women's Medical University, Tokyo, Japan.

ORCID-Profile: Tomomi Kogiso, Motoyuki Otsuka

Förderung

  • Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology,
  • Japan Agency for Medical Research and Development
  • National Center for Global Health and Medicine, Grant/Award

Zitieren

APA

Kogiso, T., Takayanagi, K., Ishizuka, T., Otsuka, M., Inai, K., Ogasawara, Y., Horiuchi, K., Taniai, M., & Tokushige, K. (2024). Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease. PLOS ONE, 19(1), e0296375. https://doi.org/10.1371/journal.pone.0296375

Vancouver

Kogiso T, Takayanagi K, Ishizuka T, Otsuka M, Inai K, Ogasawara Y, et al. Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease. PLOS ONE. 2024;19(1):e0296375. doi:10.1371/journal.pone.0296375

BibTeX
@article{Kogiso2024,
  author = {Kogiso, Tomomi and Takayanagi, Kayo and Ishizuka, Tsutomu and Otsuka, Motoyuki and Inai, Kei and Ogasawara, Yuri and Horiuchi, Kentaro and Taniai, Makiko and Tokushige, Katsutoshi},
  title = {Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {1},
  pages = {e0296375},
  doi = {10.1371/journal.pone.0296375}
}
Kostenlos starten →